SEATTLE – December 2004 – An Application to Present is now available on www.investnorthwest.org for the Invest Northwest 2005 CEO & Investor Conference. The Pacific Northwest’s only bioscience investment forum, Invest Northwest is organized by the Washington Biotechnology & Biomedical Association (WBBA) in collaboration with several other regional life science groups. It will be held April 26 - 27, 2005 in downtown Seattle.
Soquel, California – December 7, 2004 – Hosted by BC Biotech, BioAlberta, and BIOTECanada, the 3rd Annual BioPartnering North America conference (BPN, will take place in Vancouver, B.C., Canada at the Westin Bayshore Resort & Marina on February 6-8, 2005. Commenting on BPN, Barry Gee, Director, Operations and Communications, BC Biotech said, "In its short history, BPN has already established itself as one of the most valuable partnering events in the world. We're incredibly proud to host the conference here in British Columbia, and look forward to once again welcoming the international biotechnology community to our province.”
Now in its 3rd year, BioPartnering North America (BPN) continues to attract top decision makers from pharmaceutical and biotech companies worldwide. Taking place February 6-8 in Vancouver, B.C., BPN has already attracted pharmaceutical companies from Japan, Europe, the U.S. and Canada. The number of pharmaceutical companies attending BPN 2005 is up over 50% so far this year and continues to grow.
OTTAWA, Nov. 10 /CNW Telbec/ - The Ottawa Life Sciences Council today announced the jury selection of the finalists in Canada's Top 10 Life Science Companies Competition. Two BC companies ARC Pharmaceuticals Inc. andInimex Pharmaceuticals, Inc. were named finalists in the Early stage category.
VANCOUVER – Premier Gordon Campbell opened the Leading Edge Technology Centre in downtown Vancouver today, bringing B.C.’s leading technology industry associations and support organizations together under one roof for the first time to help promote B.C. as an innovative and emerging world leader in technology enterprise.
OTTAWA, Sept. 30 /CNW Telbec/ - Speaking to the membership of BC Biotech, Janet Lambert, President of BIOTECanada offered call to action for all Canadians, "When I think about how Canadians tolerate the complete absence of responsible debate on biotechnology, I shake my head in dismay. These technologies are transforming our lives and yet no one is discussing them in any meaningful way. This silence is not part of a grand design to hoodwink society or bypass the democratic process. The culprit is the lack of responsible leadership in the various groups that should be fostering debate. We, as citizens, are failing our democracy. And mea culpa, I include myself."
OTTAWA, Sept. 28 /CNW Telbec/ - Canadian biotech industry leaders are meeting with federal decision makers about biotechnology's role in addressing social and economic challenges as part of Canada's first ever National Biotech Week, which will be held from Sept. 27 to Oct. 1. There will be more than 50 other events from Vancouver to Halifax to celebrate the imagination and innovation of Canadian scientists.
BC Biotech today announced that David M. Hall, Chief Financial Officer of Angiotech Pharmaceuticals has been elected Chair of the organization’s Board of Directors. In addition, John DeLucchi, National Leader of the Life Sciences Practice, PricewaterhouseCoopers and Hector MacKay-Dunn, Q.C., Senior Partner with Farris, will join the Board of Directors.
September 23, 2004 - Ottawa ON - Gowling Lafleur Henderson LLP (Gowlings) today announced it is sponsoring a contest that will grant first year university tuition to the Grade 12 student who writes the winning essay on "The Benefits of Biotechnology to Canada". Gowlings' Life Sciences industry group unveiled the news at BIOTECanada's kick-off breakfast for National Biotech Week.
OTTAWA, Sept. 20 /CNW Telbec/ - Canada's inaugural National Biotech Week kicks off today with the launch of the official Web site, www.imagenenation.ca.
BIOTECanada is proud to welcome an exciting group of partners on board to help the association and its many partners build a successful inaugural Biotech Week event.
BIOTECanada Government Relations Flash - For the second time in only seven months, Prime Minister Paul Martin announced his new Cabinet on July 20th, 2004. Despite speculation that Ralph Goodale would be moved from the Finance portfolio to take on the challenge of House Leader in a minority government situation, he has remained as Minister of Finance. Instead, Toni Valeri will be the Leader of the Government in the House of Commons. Deputy Prime Minister and Minister of Public Security, Anne McLellan has kept her position as did Natural Resources Minister John Efford, Treasury Board President Reg Alcock andInternational Trade Minister Jim Peterson.
VICTORIA -- Premier Gordon Campbell travelled to the birthplace of the biotechnology industry on Monday to attract some of its offspring -- drug makers, life science researchers and genetic engineers -- to British Columbia.
Victoria biotechnology companies will be part of a B.C. trade delegation led by Premier Gordon Campbell leaving Sunday for the world's biggest gathering on biotech in San Francisco.
VANCOUVER – On the heels of KPMG’s international study rating British Columbia as one of the most cost-competitive areas in which to conduct business, B.C.’s Biotech community – led by Premier Gordon Campbell and the Honourable John Les, Minister of Small Business and Economic Development – will be promoting B.C. at BIO 2004 as the premiere destination for technology and investment.
OTTAWA, May 21 /CNW/ - BIOTECanada is reassured by the Supreme Court decision in the Monsanto vs. Percy Schmeiser case supporting Intellectual Property protection in Canada.
More than half of the entire country's biotech financing was centred in Vancouver last year thanks to the strong performance of three powerhouse companies, a study shows.
Vancouver, British Columbia – BC Biotech is pleased to announce that four of the six 2004 BIOTECanada Awards recently presented went to British Columbia companies or individuals. They are: Paul Hastings, President & CEO of QLT Inc. for Contribution to the Association; ARC Pharmaceuticals and Clera Inc. as Most Promising Early Stage Companies; Angiotech Pharmaceuticals for Biotech Company of the Year.
BURNABY - Inquiring minds will test their biotech mettle on Friday when B.C. Institute of Technology and BC Biotech co-host a day of research in action at BCIT's Burnaby campus.
The BHRC and Aon Consulting are pleased to announce the 3rd Annual Biotechnology Compensation Survey. Created to help Canadian Biotechnology companies define, design, and deploy compensation and reward strategies that drive organizational success.
Vancouver, British Columbia - BC Biotech today announced the winners of the 2004 BC Biotechnology Awards. They are: · Dr. Terrance Snutch, Vice-President and Chief Scientific Officer, NeuroMed Technologies for Researcher of the Year · BC Cancer Agency’s Michael Smith Genome Sciences Centre for Innovation and Achievement – for the sequencing of the SARS genome · Angiotech Pharmaceuticals for Life Sciences Company of the Year · Dr. Julia Levy, Executive Chairman, Scientific Advisory Board, QLT Inc. for Lifetime Achievement. These awards are presented annually by BC Biotech to recognize individuals and organizations that have made outstanding contributions to the development of British Columbia’s biotechnology industry, and to increase public awareness and understanding of biotechnology in the province.
Join Simon Fraser University and Industry Canada in their presentation of the March 3 rd "Face of Innovation" studio interview event featuring: Natalie Dakers, President & CEO & Dr. Terrance (Terry) Snutch, VP & CSO of NeuroMed Technologies Inc.Learn how a world-renowned research scientist (and SFU graduate) teamed up with a highly experienced UBC technology transfer officer to take a spin-off biotech company from 3 to 32 employees over the past six years,attracting $68 million in venture capital financing,building an extensive patent portfolio and advancing its R&D pipeline including its lead program for chronic pain.
Technology Vision Group LLC (TVG) is pleased to announce the 2nd Annual BioPartnering North America (BPN) conference will be held on February 8-10, 2004, at the Westin Bayshore Resort and Marina in Vancouver, B.C., Canada. BPN is produced by Technology Vision Group LLC with the support of local hosts - BC Biotech, BIOTECanada and BioAlberta.
SOQUEL, Calif., Jan. 27 /PRNewswire/ -- Technology Vision Group LLC (TVG) is pleased to announce that last minute preparations are underway for the 2nd Annual BioPartnering North America (BPN) conference in Vancouver, February 8- 10, 2004. BPN will be held at the Westin Bayshore Resort and Marina in Vancouver, B.C., Canada, as a partnership between Technology Vision Group LLC, BC Biotech, BioAlberta, and BIOTECanada with the support of key industry leaders.
Inex Pharmaceuticals Corp. (IEX: TSX) has taken a big step forward thanks to a pact with a U.S.-based pharmaceutical company that could translate to more than US$75 million for the local firm. Last week the Burnaby drug developer, which employs about 175, announced a partnership with Enzon Pharmaceuticals Inc. (ENZN: Nasdaq), a mid-sized biotech headquartered in Bridgewater, New Jersey.
Last year's inaugural BioPartnering North America conference has kept Vancouver at the top of biotech executives' minds continent-wide. With the second Biopartnering North America conference scheduled for February 8 to 10 at the Westin Bayshore Resort and Marina, Vancouver is preparing to once again host a who's who of North American biotechnology.
Call it one of my many little pet peeves, but I find it irritating that conversations centered around life sciences in B.C. rarely include medical devices. Personally, I would like to see that change. To help the process, here are three good reasons why medical device firms deserve more attention.
In the world of biotechnology finance, 2003 came in with a whimper and finished with a roar. The strong performance of the U.S. life science indexes and significant increases in the share price of a number of our local biotechnology companies led me to announce the end of the biotechnology bear market in my June column.
Victor Ling has spent his professional life grappling with the conundrum of cancer. And as he helps guide the BC Cancer Agency forward, bolstered by world-class research and a top-notch team, he's confident that the many-headed disease can be beaten.
The 2nd Annual BioPartnering North America Conference is just around the corner. The program has now been finalized and BC companies and researchers will be featured prominently in two important sessions.
The B.C.-led quest for a human vaccine against SARS should get a boost today when American experts meet their counterparts at the BC Centre for Disease Control to forge collaborations on fast-tracked experiments in animals like ferrets and monkeys.
Soquel, California – January 7, 2004 - Technology Vision Group LLC (TVG) is pleased to announce that it has launched an evolutionary internet network and business intelligence system to showcase the companies and the people driving bioscience innovation around the world. All registered delegates of the 2nd Annual BioPartnering North America conference in Vancouver, February 8-10, 2004 will have access to biopartnering.com, a dynamic web-based product offering a variety of valuable functions which delegates may customize according to their personal needs.